Information Journal Paper
APA:
CopyDE JESUS ACOSTA, A., LAHERU, D., & MAITRA, A.. (2014). A PHASE II STUDY OF THE GAMMA SECRETASE INHIBITOR RO4929097 IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC PANCREATIC ADENOCARCINOMA. INVESTIGATIONAL NEW DRUGS, 32(4), 739-745. SID. https://sid.ir/paper/676410/en
Vancouver:
CopyDE JESUS ACOSTA A., LAHERU D., MAITRA A.. A PHASE II STUDY OF THE GAMMA SECRETASE INHIBITOR RO4929097 IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC PANCREATIC ADENOCARCINOMA. INVESTIGATIONAL NEW DRUGS[Internet]. 2014;32(4):739-745. Available from: https://sid.ir/paper/676410/en
IEEE:
CopyA. DE JESUS ACOSTA, D. LAHERU, and A. MAITRA, “A PHASE II STUDY OF THE GAMMA SECRETASE INHIBITOR RO4929097 IN PATIENTS WITH PREVIOUSLY TREATED METASTATIC PANCREATIC ADENOCARCINOMA,” INVESTIGATIONAL NEW DRUGS, vol. 32, no. 4, pp. 739–745, 2014, [Online]. Available: https://sid.ir/paper/676410/en